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Abstract
Vestibular schwannoma and endolymphatic hydrops are two conditions that may present with similar audio-vestibular 
symptoms. The association of the two in the same patient represents an unusual finding that may lead clinicians to 
errors and delays in diagnosis and clinical management of affected subjects. We discuss the case of a patient with an 
intrameatal vestibular schwannoma reporting symptoms suggestive for ipsilateral endolymphatic hydrops. The patient 
presented with fluctuating hearing loss, tinnitus, and acute rotatory vertigo episodes, and underwent a full audiological 
evaluation and imaging of the brain with contrast-enhanced Magnetic Resonance Imaging. Clinical audio-vestibular 
and radiological examination confirmed the presence of coexisting vestibular schwannoma and endolymphatic 
hydrops. Hydrops was treated pharmacologically; vestibular schwannoma was monitored over time with a wait and 
scan protocol through conventional MRI. The association of vestibular schwannoma and endolymphatic hydrops is 
rare, but represents a possible finding in clinical practice. It is therefore recommended investigating the presence of 
inner ear disorders in patients with vestibular schwannoma and, similarly, to exclude the presence of this condition in 
patients with symptoms typical of inner ear disorders.
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INTRODUCTION
Vestibular schwannomas (VS), also known as 
acoustic neuromas, are benign neoplasms originating 
from the Schwann cells of the eighth cranial nerve and 
present most frequently in subjects between 30 and 60 
years1. VS have a prevalence of 1.4-2.1 in 10.000 people2,3, 
and represent 5% to 10% of all intracranial tumors, and 
80% to 90% of neoplasms of the cerebellopontine angle4.
VS presenting symptoms usually include slowly 
progressive sensorineural hearing loss, fullness and 
tinnitus associated to vestibular disorders in 16-70% of 
cases; balance disorders can present with acute rotatory 
vertigo and/or dizziness5,6. Medical history, clinical 
examination and routine audio-vestibular examination 
alone cannot diagnose VS; diagnosis must be confirmed 
by high-resolution Magnetic Resonance Imaging (MRI) 
with intravenous gadolinium-based contrast7. Along with 
imaging technology improvements, the number of VS 
diagnosis has increased including smaller schwannomas 
previously overlooked8. 
The presenting symptoms of VS can also be found 
in other inner ear disorders such as endolymphatic 
hydrops (ELH); nevertheless, inner ear disorders may be 
present in patients with VS9. ELH is a disorder of the inner 
ear characterized by episodic attacks of vertigo, tinnitus, 
fluctuating hearing loss, ear fullness, and progressive 
loss of the audio-vestibular function10.
Differential diagnosis plays a central role for a 
correct diagnostic and therapeutic management of VS 
patients; at the same time, it is important not to overlook 
other concomitant inner ear disorders10. 
In this paper, we describe the case of a patient 
with fluctuating hearing loss, tinnitus and acute rotatory 
vertigo episodes, who presented an intrameatal vestibular 
schwannoma and a symptomatology suggestive for 
ipsilateral endolymphatic hydrops. 
CASE PRESENTATION
A 67-year-old man was admitted to the 
Otolaryngology Department of the Policlinico Umberto 
I, Sapienza University of Rome in December 2013 with 
a three-year history of fluctuating hearing loss in the left 
ear and vertigo attacks lasting 2 to 6 hours associated 
to intense nausea and vomiting (4-6 episodes/year). Last 
episode occurred one month before admission. 
After admission, patient underwent a complete 
otolaryngology examination with otoscopy, Pure-Tone 
Audiometry (PTA), Auditory Brainstem Response (ABR), 
Distorsion-Product Otoacoustic Emissions (DPOAE), 
Infrared Videonystagmography (IR-VNG) for spontaneous 
and gaze-evoked nystagmus and Fitzgerald-Hallpike 
caloric stimulation. Vestibular examination was completed 
with Cervical Vestibular Evoked Myogenic Potential 
(c-VEMP) and Ocular Vestibular Evoked Myogenic 
Potential (o-VEMP) response recording. Written informed 
consent was obtained from the patient for all the diagnostic 
and therapeutic procedures performed.
The patient had a normal otoscopy; PTA showed 
a mild sensorineural hearing loss in the right ear 
with an average auditory threshold of 37.50 dB and 
a moderate sensorineural hearing loss in the left ear 
with an average threshold of 61.25 dB, more evident 
for mid-low frequencies. Weber test lateralized to the 
right at all frequencies. Speech Discrimination was in 
accordance with PTA; no alterations were found at ABR 
(Table 1); DPOAE amplitudes were reduced bilaterally 
with a significant reduction in the left ear compared to 
the contralateral ear (Figure 1). No spontaneous or gaze-
evoked nystagmus was found at IR-VNG; left hyporeflexia 
was observed at the caloric test. The first c-VEMP complex 
of biphasic wave p13-n23 and the n10 response of the 
o-VEMP to Bone Conducted Vibration and Air Conducted 
Sound were normally evoked bilaterally. 
Audiological examination was followed by a 
conventional MRI of the brain with gadolinium-based 
contrast agent performed in the axial, sagittal and 
coronal planes focusing on the eight cranial nerve and 
cerebellopontine angle; heavily T2-weighted sequences 
revealed an intrameatal mass with cystic and solid 
components measuring approximately 7 x 4 mm on the 
left side consistent with vestibular schwannoma (Figure 2). 
During the following 30 months, the patient 
Table 1. Auditory Brainstem Response recording in our patient. 
No alterations can be seen for waveforms and latencies in both 
sides.
I III V I-III III-V I-V
Right 1.58 3.72 5.68 2.13 1.97 4.10
Left 1.68 3.81 5.63 2.12 1.82 3.95
Figure 1. Distorsion Product Otoacoustic Emissions (DPOAE) 
amplitudes were reduced bilaterally with a significant reduction in the 
left ear compared to the contralateral ear.
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experienced fluctuating hearing loss in the left ear 
associated to acute vertigo attacks monitored over time 
with PTA and IR-VNG; exams documented a fluctuation of 
hearing threshold in the mid-low frequency range in the 
left ear with average auditory threshold for frequencies 
500-4000 Hz of 53.75 dB in March 2013, 32.5 dB in 
February 2014, 45.75 in March 2015 and 61.25 in May 
2016 (Figure 3). When recorded during the vertigo attack, 
IR-VNG showed a spontaneous left beating nystagmus. 
The patient also reported the onset of a stable high-pitch 
tinnitus in the left ear one year after initial admission to 
our unit.
The results of the audiological evaluation 
during follow up led towards a diagnosis of left VS 
associated to an ipsilateral ELH. Diagnosis of ELH was 
posed according to AAO-HNS Committee on Hearing 
and Equilibrium classification criteria11,12 but was not 
confirmed radiologically due to unavailability of 3-Tesla 
MRI. Hydrops was treated pharmacologically with 
betahistine-dihydrochloride during crisis and long-term 
cinnarizine plus chlorthalidone associated to low sodium 
diet following our internal management protocol; VS 
was monitored over time with a wait and scan protocol 
through conventional MRI.
Figure 2. Heavily T2-weighted Magnetic Resonance Imaging sequences 
in the axial (A) and coronal (B) planes revealed an intrameatal mass with 
cystic and solid components measuring approximately 7 x 4 mm on the 
left side consistent with vestibular schwannoma.
 
Figure 3. Pure-Tone Auditory threshold for the left ear between March 2013 and May 2016. A clear sensorineural fluctuation of hearing threshold can 
be seen for the mid-low frequencies. A: 2013; B: 2014; C: 2015; D: 2016.
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DISCUSSION
The presentation of simultaneous VS and ELH on 
the same side in the same patient is uncommon and has 
seldom been described in the literature13-16. Although the 
two pathologies are most probably of independent origin 
and should be considered separate entities, presenting 
and ongoing symptoms may overlap and may cause 
an incorrect treatment of the cochlear disorder (i.e. 
misdiagnosis of the endolymphatic hydrops), a potential 
delay in VS diagnosis (i.e. postponing the execution of a 
MRI) or a potential misinterpretation of VS evolution (i.e. 
attributing symptoms to VS growth instead of inner ear 
dysfunction, or vice-versa)13,16-19. 
In such cases, it is always puzzling to attribute 
the vestibular symptoms to the inner ear or to the 
retrocochlear condition. Several studies discussed the 
origin (retrocochlear or cochlear) of audio-vestibular 
symptoms in patients with VS, suggesting that vertigo 
and hearing loss may also have a peripheral origin, 
possibly induced by tumor-related vascular alterations 
of the inner ear, rather than being exclusively linked to 
a direct pressure of the tumor on the vestibulocochlear 
nerves20,21. Roosli et al studied temporal bones from 32 
patients with unilateral VS, finding significantly more hair 
cell loss, cochlear neuronal loss and decreased pure tone 
average when compared with the opposite ear; however, 
tumor size, distance from the cochlea, and nerve of origin 
did not correlate with structural changes found in the 
cochlea20. 
Due to the varying and fluctuating symptoms, 
the clinical diagnosis of ELH may be difficult22. The 
role of new imaging techniques is gaining importance 
in ELH diagnosis, since conventional MRI is unable to 
distinguish the endolymphatic from the perilymphatic 
compartments within the inner ear23. In the recent years, 
several efforts have been made to develop reliable 
imaging able to identify ELH; some inner ear imaging 
techniques enable visualizing morphological changes in 
the cochlea and the vestibulum in vivo24. Current research 
demonstrates the validity of Locally Enhanced Inner Ear 
MRI (LEIM) after intratympanic contrast agent application 
and 3-Tesla MRI performed with intravenous gadolinium 
with 3D-FLAIR sequences for the diagnosis and grading 
of ELH; these techniques have shown similar sensitivity 
to histopathological series in identifying ELH25-27. The 
degree of perilymphatic enhancement in 3-Tesla MRI also 
depend on the interval between the intravenous contrast 
administration and imaging. Research showed that a 
4-hour delay results in greater contrast enhancement 
within the perilymph28,29. Jerin et al reported a case of a 
patient with VS and endolymphatic hydrops, in which ELH 
was revealed with the use of an inner ear LEIM MRI with 
an axial 3D Real-IR sequence; the authors recommended 
performing locally contrast-enhanced inner ear MRI 
in those cases in which an ELH is suspected14. In a 
study from Kentala and Pyykkö, the authors retrieved 
information on 127 patients with VS and 243 patients 
with ELH and found that 38% of the VS patients had the 
full triad of vertigo, hearing loss and tinnitus and vertigo 
mimicked that in ELH in 14% of cases19. In a recent study 
to verify whether vertigo in patients with VS correlates 
to vestibular endolymphatic hydrops, Naganawa et 
al studied 15 patients with unilateral VS using a non-
contrast-enhanced 3D FLAIR MRI and reported vestibular 
hydrops in 4/15 cases; however, no significant correlation 
between vertigo and hydrops was found15.
In our patient, the two pathological conditions 
coexist but are most probably unrelated. The full 
audiological and radiological protocol performed allowed 
to identify separately both cochlear and retrocochlear 
disorders, although the diagnosis of ELH was not 
confirmed by imaging due to unavailability of 3-Tesla 
MRI (the availability of 3-Tesla scanners is still limited 
in many hospitals) or, as suggested by some authors, 
electrocochleography30; consequently, ELH diagnosis 
was only based on symptoms reported by the patient 
over the years associated to the results of the auditory 
and vestibular evaluation performed initially and during 
follow up and to patient’s response to therapy. 
CONCLUSION
Although current literature supports the notion of a 
peripheral origin of vertigo in patients with small vestibular 
schwannomas, it is always recommended in patients with 
VS to also investigate possible coexisting independent 
inner ear disorders such as ELH, especially when a 
fluctuation in audio-vestibular symptoms is documented. 
When available, a 3-Tesla MRI performed at 4 hours 
post-intravenous gadolinium with 3D-FLAIR sequences 
or a locally contrast-enhanced inner ear MRI to detect 
endolymphatic hydrops may be useful to confirm ELH. At 
the same time, as widely documented in the literature, it 
is always recommended performing gadolinium contrast-
enhanced MRI in patients with unilateral hearing loss 
and symptoms suggesting a peripheral origin to exclude 
retrocochlear lesions such as VS. Unfortunately, the need 
for a thorough neuro-otological work-up including MRI 
scanning can still be overlooked in the cases in which it 
appears to be a clear peripheral etiology for the hearing 
loss such as in endolymphatic hydrops.
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